Reach Us +1-217-403-9671
Vascular Targeted Nanoparticles For Imaging And Treatment Of Brain Tumors | 7433
ISSN: 2167-7689

Pharmaceutical Regulatory Affairs: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Vascular targeted nanoparticles for imaging and treatment of brain tumors

2nd International Conference and Exhibition on Pharmaceutical Regulatory Affairs

Karnati Lakshmi Deepika

Posters: Pharmaceut Reg Affairs

DOI: 10.4172/2167-7689.S1.007

The position of the pharmaceutical industry in the global market is not parallel as compared to other information and technology based industries. Among the Leading industries, the pharmaceutical industry far behind in the growth rate, innovative research, capital investment and government regulations are concern. Most of the countries are not focused on core research, they just depend on bulk production of the generic drugs. The pharmaceutical industries come at the 9th position while electronic & IT industry stands first in respect of growth rate. The new rule regarding the product patent had made a huge impact on growth of the pharmaceutical sector in developing country. Many of the small-scale pharmaceutical company in developing countries are either closed down or stopped their business activities in the last few years. It is due to un-favorable government policies, their inability to invest capital in research of new drugs which is essential to compete with large companies in the changing business environment. The world pharmaceuticals market is forecast to grow with 11% percent or more from until 2020 which can be increased if companies invest more in drug research sector as well promotion, shortens the period of clinical trials and specially the government has to focus more on growth of small scale sector in developing countries by liberalization of regulations and policies like exemptions in taxes and more research oriented funding to improve the future of the pharmaceutical sector globally.
K. Vaishnavi is currently pursuing her 2nd year M. Pharmacy in Pharmaceutical Quality Assurance from JSS University, Mysore. She has done her graduation from Rajiv Gandhi University, Bangalore. She has attended 63rd IPC and presented a poster on ?GMP- A comparison between regulated and rest of the world countries? and also attended an International conference on ?Recent advances in pharmaceutical sciences? held by the Kathmandu University in Nepal and presented a poster on ?Good Laboratory Practice?.